PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Structural Genomics Consortium, University of Toronto, Toronto, ON, Canada.\', \'Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.\', \'Department of Microbiology-Immunology, Northwestern University, Center for Structural Genomics of Infectious Diseases, Feinberg School of Medicine, Chicago, IL, USA.\', \'Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.\', \'Program of Pharmacology, Weill Cornell Medical College of Cornell University, New York, NY, USA.\', \'Departments of Pharmacological Sciences and Oncological Sciences, Mount Sinai Center for Therapeutics Discovery, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.\', \'Alzheimer\'s Research UK UCL Drug Discovery Institute, University College London, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1177/24725552211026261
?:hasPublicationType
?:journal
  • SLAS discovery : advancing life sciences R & D
is ?:pmid of
?:pmid
?:pmid
  • 34192965
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34192965>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34192965>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all